Kovitz Investment Group Partners’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
CCA
KF
AWM
KAS
ASN
Kovitz Investment Group Partners's BTAL Position: Q4 2025 in Review
Kovitz Investment Group Partners sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 2,221,703 shares — an estimated $35.4M sold.
Kovitz Investment Group Partners first reported a position in BTAL in Q3 2024 and held it in 5 quarters. The position peaked at $37.7M in Q1 2025. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.
- Kovitz Investment Group Partners reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
- Kovitz Investment Group Partners sold 2,221,703 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $35.4M.
- Kovitz Investment Group Partners first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2024 and held it in 5 quarters.
- Kovitz Investment Group Partners's AGF US Market Neutral Anti-Beta Fund position peaked at $37.7M in Q1 2025.
- 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.
Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.